The 2002 Doha Declaration reaffirmed that the TRIPS Agreement should not prevent members from taking the necessary measures to protect public health. Despite this recognition, less developed countries have argued that flexible TRIPS provisions, such as compulsory licensing, are almost impossible to enforce. Less developed countries, in particular, cited their young domestic manufacturing and technology industries as evidence of the imprecision of the policy. Although this means that there will be no new version of TRIPS in the near future, it remains an important treaty for at least three reasons: the number of countries that have signed it (158 from 2014), the main “stick” for the application of copyright and patent standards against these countries and the main obstacle to the reassessment of these standards, such as the minimum “Life Plus 50 years” of copyright duration.